Ajanta Pharma consolidated net profit declines 17.13% in the March 2018 quarter

Sales rise 11.22% to Rs 530.31 crore

Net profit of Ajanta Pharma declined 17.13% to Rs 94.49 crore in the quarter ended March 2018 as against Rs 114.02 crore during the previous quarter ended March 2017. Sales rose 11.22% to Rs 530.31 crore in the quarter ended March 2018 as against Rs 476.81 crore during the previous quarter ended March 2017.

For the full year,net profit declined 7.54% to Rs 468.64 crore in the year ended March 2018 as against Rs 506.83 crore during the previous year ended March 2017. Sales rose 6.46% to Rs 2130.86 crore in the year ended March 2018 as against Rs 2001.64 crore during the previous year ended March 2017.

 

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales530.31476.81 11 2130.862001.64 6 OPM %26.3133.05 -30.9034.32 - PBDT144.66162.90 -11 682.14709.38 -4 PBT128.02143.98 -11 622.55648.17 -4 NP94.49114.02 -17 468.64506.83 -8

Powered by Capital Market - Live News